Get started
Author

Harikrishnan Balachandran

Observed name: Balachandran, Harikrishnan
Institution: Duke University
Observed institutions: Beth Israel Deaconess Medical Center, Harvard University, Duke University, UNSW Sydney, Duke Medical Center, Dallas VA Medical Center, Duke University Health System, Kirby Institute, The University of Texas Southwestern Medical Center
ORCID: 0000-0001-9336-0555
Observed ORCID: 0000-0001-9336-0555
OpenAlex ID: A5030798404
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
2017 · Norbert Pardi, Michael J. Hogan, et al. · Nature · 883
PDF
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
2010 · Sampa Santra, Hua-Xin Liao, et al. · Nature Medicine · 235
PDF
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys
2011 · Norman L. Letvin, Srinivas S. Rao, et al. · Science Translational Medicine · 184
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
2017 · Todd Bradley, Justin Pollara, et al. · Nature Communications · 143
PDF
Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
2021 · Arunasingam Abayasingam, Harikrishnan Balachandran, et al. · Cell Reports Medicine · 78
PDF
Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib
2009 · Disha Dumka, Poonam Puri, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 49
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses
2022 · Harikrishnan Balachandran, Chansavath Phetsouphanh, et al. · Cell Reports · 46
PDF
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
2021 · Deborah L. Burnett, Katherine J.L. Jackson, et al. · Immunity · 44
Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens
2012 · Sampa Santra, Mark Muldoon, et al. · Virology · 44
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost
2015 · Sandrine L. Hulot, Bette Korber, et al. · Journal of Virology · 43
RecombinantMycobacterium bovisBCG Prime-Recombinant Adenovirus Boost Vaccination in Rhesus Monkeys Elicits Robust Polyfunctional Simian Immunodeficiency Virus-Specific T-Cell Responses
2009 · Mark J. Cayabyab, Birgit Korioth-Schmitz, et al. · Journal of Virology · 42
SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents
2022 · Pablo Garcia-Valtanen, Christopher M. Hope, et al. · Cell Reports Medicine · 41
PDF
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
2023 · Romain Rouet, Jake Y. Henry, et al. · Nature Communications · 40
PDF
Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys
2009 · Ariane Rodríguez, Ratna Mintardjo, et al. · Vaccine · 37
Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques
2016 · Donatella Negri, Maria Blasi, et al. · Molecular Therapy · 35
PDF
Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease
2010 · Roland C. Zahn, Melisa D. Rett, et al. · Blood · 28
Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes
2014 · Mohammed Asmal, Corinne Luedemann, et al. · Virology · 25
Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
2016 · Venkateswarlu Chamcha, Sunil Kannanganat, et al. · Open Forum Infectious Diseases · 15
PDF
Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Vectors Prime for Strong Cellular Responses to Simian Immunodeficiency Virus Gag in Rhesus Macaques
2014 · Jaimie D. Sixsmith, Michael W. Panas, et al. · Clinical and Vaccine Immunology · 14
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates
2018 · Kevin O. Saunders, Sampa Santra, et al. · Journal of Virology · 12
Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates
2012 · Diane L. Bolton, Sampa Santra, et al. · Vaccine · 11
FcαRI (CD89) is upregulated on subsets of mucosal and circulating NK cells and regulates IgA-class specific signaling and functions
2024 · Kyle W. Kroll, Brady Hueber, et al. · Mucosal Immunology · 7
PDF
High activation levels maintained in receptor‐binding domain–specific memory B cells in people with severe coronavirus disease 2019
2022 · Money Gupta, Harikrishnan Balachandran, et al. · Immunology and Cell Biology · 7
PDF
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies
2025 · Ohan Mazigi, David B. Langley, et al. · Proceedings of the National Academy of Sciences · 6
Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections
2016 · Mohammed Asmal, Sophie Lane, et al. · Virology · 5
PDF
Works count: 40
Citation count: 2,098
H-index: 17
I10-index: 21
Year
Topic
Type